Noninvasive Prenatal Testing (NIPT) Natera


Natera noninvasive prenatal testing (NIPT) is a single nucleotide polymorphism (SNP)-based method that analyzes genetic information in fetal cell-free DNA in maternal blood to determine risk for specific fetal chromosomal and subchromosomal abnormalities.

We offer two NIPT options through Natera: The PANORAMA PRENATAL PANEL, which screens for triploidy, 22q11.2 deletion syndrome, and analyzes chromosomes 13, 18, 21, X, and Y, and the PANORAMA EXTENDED PANEL, which screens for triploidy, 22q11.2 deletion syndrome, 1p36 deletion syndrome, cri du chat syndrome, Angelman syndrome, Prader-Willi syndrome, and analyzes chromosomes 13, 18, 21, X, and Y.


Specimen Requirements

Whole blood: Two 10 mL BCT Streck tubes


Ordering Information

Shipping

  • Ship at room temperature

Turnaround Time

  • 7-10 days


Resources

Prenatal Test Requisition with Natera NIPT